Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Kees_Been
|
| gptkbp:developedBy |
small molecule drugs
therapies for Parkinson's disease |
| gptkbp:focusesOn |
neurodegenerative diseases
lysosomal biology |
| gptkbp:foundedYear |
2011
|
| gptkbp:founder |
gptkb:Gary_Kelloff
gptkb:Kees_Been gptkb:Peter_Lansbury |
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lysosomal Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:target |
gptkb:Parkinson's_disease
other neurodegenerative diseases |
| gptkbp:website |
https://www.lyso-tx.com/
|
| gptkbp:bfsParent |
gptkb:Jean-François_Formela
|
| gptkbp:bfsLayer |
7
|